1. Novel lncRNA-miRNA-mRNA Competing Endogenous RNA Triple Networks Associated Programmed Cell Death in Heart Failure
   Yu Zheng et al, 2021, Front. Cardiovasc. Med. CrossRef
2. Signaling pathways and targeted therapy for myocardial infarction.
   Qing Zhang et al, 2022, Signal Transduct Target Ther CrossRef
3. Evidence and Characteristics of Traditional Chinese Medicine for Coronary Heart Disease Patients With Anxiety or Depression: A Meta-Analysis and Systematic Review
   Baofu Wang et al, 2022, Front. Pharmacol. CrossRef
4. Tanshinone IIA Accomplished Protection against Radiation-Induced Cardiomyocyte Injury by Regulating the p38/p53 Pathway
   Gang Wang et al, 2022, Mediators of Inflammation CrossRef
5. Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction
   Yu Wang et al, 2022, Front. Pharmacol. CrossRef
6. Tanshinone IIA ameliorates myocardial ischemia/reperfusion injury in rats by regulation of NLRP3 inflammasome activation and Th17 cells differentiation
   Dan Li et al, 2022, Acta Cir. Bras. CrossRef
7. Cellular mechanisms and molecular pathways linking bitter taste receptor signalling to cardiac inflammation, oxidative stress, arrhythmia and contractile dysfunction in heart diseases
   Menizibeya O. Welcome et al, 2022, Inflammopharmacol CrossRef
8. A Pharmacological Review of Tanshinones, Naturally Occurring Monomers from Salvia miltiorrhiza for the Treatment of Cardiovascular Diseases
   Ye Yang et al, 2023, Oxidative Medicine and Cellular Longevity CrossRef
9. The traditional Chinese medicines treat chronic heart failure and their main bioactive constituents and mechanisms
   Jie Chen et al, 2023, Acta Pharmaceutica Sinica B CrossRef
10. A review on experimental surgical models and anesthetic protocols of heart failure in rats
    Ahmed Farag et al, 2023, Front. Vet. Sci. CrossRef
11. Post-myocardial infarction fibrosis: Pathophysiology, examination, and intervention
    Xiaoying Yin et al, 2023, Front. Pharmacol. CrossRef
12. The therapeutic effect of tanshinone IIA in mouse astrocytes after treatment with Angiostrongylus cantonensis fifth-stage larval excretory-secretory products
    Kuang-Yao Chen et al, 2023, Journal of Microbiology, Immunology and Infection CrossRef
13. Screening and identification of effective components from modified Taohong Siwu decoction for protecting H9c2 cells from damage
    Ya-chao Wang et al, 2023, In Vitro Cell.Dev.Biol.-Animal CrossRef
14. Protective effects of tanshinone IIA on Porphyromonas gingivalis-induced atherosclerosis via the downregulation of the NOX2/NOX4-ROS mediation of NF-κB signaling pathway.
    Yan Xuan et al, 2023, Microbes Infect CrossRef
15. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?
    Milton Packer, 2023, European J of Heart Fail CrossRef
16. The role of matrix metalloproteinase 9 in fibrosis diseases and its molecular mechanisms
    Yuling Wang et al, 2024, Biomedicine & Pharmacotherapy CrossRef
17. STS ⅡA inhibited angiogenesis of lung adenocarcinoma by activating FOXO3 to inhibit CXCL1/STAT3/VEGF pathway
    Bu Wang et al, 2024, Toxicon CrossRef
18. New Insights into Mechanisms Traditional Chinese Medicine for Allergic Rhinitis by Regulating Inflammatory and Oxidative Stress Pathways
    Zhu Qin et al, 2024, JAA CrossRef
19. Optimized New Shengmai Powder modulation of cAMP/Rap1A signaling pathway attenuates myocardial fibrosis in heart failure
    Zeyu Zhang et al, 2024, Chin Med CrossRef
20. Danshen-Shanzha formula for the treatment of atherosclerosis: ethnopharmacological relevance, preparation methods, chemical constituents, pharmacokinetic properties, and pharmacological effects
    Qiong Xu et al, 2024, Front. Pharmacol. CrossRef
21. Tanshinone IIA through the PGK1/PDHK1 Pathway Affecting Macrophage Reprogramming in the Repair Process of Myocardial Infarction
    Ming Li et al, 2024, Cardiovasc Drugs Ther CrossRef
22. Therapeutic Potential of Salvia miltiorrhiza Root Extract in Alleviating Cold-Induced Immunosuppression
    Chi-Cheng Li et al, 2024, IJMS CrossRef
23. Ershen Zhenwu Decoction Suppresses Myocardial Fibrosis of Chronic Heart Failure with Heart–Kidney Yang Deficiency by Down-Regulating the Ras Homolog Gene Family Member A/Rho-Associated Coiled-Coil Kinases Signaling Pathway
    Dan Cheng et al, 2024, Journal of Ethnopharmacology CrossRef
24. Mechanistic analysis of Tanshinone IIA’s regulation of the ATM/GADD45/ORC signaling pathway to reduce myocardial ischemia-reperfusion injury
    Yiwei Sang et al, 2024, Front. Pharmacol. CrossRef